T, K., F, W., MB, S., & AI, A. (2019). Antisickling Drugs Targeting βCys93 Reduce Iron Oxidation and Oxidative Changes in Sickle Cell Hemoglobin. Frontiers in physiology, 10, 931. https://doi.org/10.3389/fphys.2019.00931
Chicago Style (17th ed.) CitationT, Kassa, Wood F, Strader MB, and Alayash AI. "Antisickling Drugs Targeting βCys93 Reduce Iron Oxidation and Oxidative Changes in Sickle Cell Hemoglobin." Frontiers in Physiology 10 (2019): 931. https://doi.org/10.3389/fphys.2019.00931.
MLA (9th ed.) CitationT, Kassa, et al. "Antisickling Drugs Targeting βCys93 Reduce Iron Oxidation and Oxidative Changes in Sickle Cell Hemoglobin." Frontiers in Physiology, vol. 10, 2019, p. 931, https://doi.org/10.3389/fphys.2019.00931.
Warning: These citations may not always be 100% accurate.